Bispecifics in Oncology and Immuno Oncology This webinar roundtable explores interesting technologies, the scientific issues, the clinical opportunities for developing multivalent biologics platforms, whether certain technologies, such as antibodies, their fragments, or non-antibody scaffolds, are superior to others, the pros and cons of such bispecifics for improving management of patients, and licensing and commercial strategies. Best Practices & Trends BioPharma Life Sciences Other Topics Webinars
Compliance 21-cfr-11 Validation Summary Report At ShareVault development, security and operations are seamlessly integrated, such that security is built into the design and 21 CFR 11 compliance validation is part of our standard quality process. Report Whitepapers validation
Datasheets Validation Package 21 cfr 11 Our 21 CFR part 11 Compliance Validation Package contains all the information, test scripts and instructions customers need to conduct their own risk assessment of our software to verify it poses no risk to patients, product quality or data integrity. Whitepapers validation
Capital Raising Landscape Infographic All investors are different. Start your capital raise with a sound grasp of the lay-of-the-land. Capital to raise Guides Infographics
Expert Guide to Selecting Medical Device Suppliers A vast majority of businesses contract suppliers to provide goods and services to supplement their internal resources. BioPharma Guides Webinars
Due Diligence Checklist This all-purpose due diligence checklist contains a list of all the standard documents any buyer or partner might want to see. . BioPharma Due Diligence Due Diligence Checklists Energy Finance Fundraising Legal Life Sciences Mergers & Acquisitions Other Industries Other Topics Real Estate Top Content
Life Sciences Due Diligence Checklist The Life Sciences due diligence checklist covers unique characteristics applicable to your industry, which buyers or partners may want to examine. BioPharma Due Diligence Life Sciences
What’s Hot and What’s Not in IO 2021? Oncology venture funding, IPOs and partnerships have been exceptionally high in deal volume and values. Cancer continues to be the leading therapeutic area in the number and size of early deals, and the oncology pipeline continues to be a rich source of both follow-on agents as well as first-in-class programs. BioPharma Life Sciences Webinars
Practical Application of Artificial Intelligence in Drug Discovery and Development In this whitepaper, learn what is artificial intelligence and how is it being applied to drug discovery, and much more. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Essential Steps to Successful Biopharma Partnering This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering. BioPharma Licensing & Partnering Life Sciences Whitepapers
Successful Biotech Licensing Negotiations In this whitepaper, Linda Pullan provides licensing negotiations insights from a biotech business development perspective. BioPharma Life Sciences Other Topics Whitepapers
A Medical Device Manufacturer's Guide to Selecting Suppliers This white paper covers when to consider using suppliers, key differences between standard / OTS and custom part suppliers, tools and methods for managing suppliers, and when and how to transition between suppliers and internal resources. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers